SYNERON MEDICAL LTD - ORD SHS (ELOS)

CUSIP: M87245102

Q1 2017 13F Holders as of 31 Mar 2017

Type / Class
Equity / ORD SHS
Total 13F shares
24,324,137
Share change
+659,418
Total reported value
$256,620,270
Put/Call ratio
0%
Price per share
$10.55
Number of holders
88
Value change
+$9,178,622
Number of buys
49
Number of sells
33

Quarterly Holders Quick Answers

What is CUSIP M87245102?
CUSIP M87245102 identifies ELOS - SYNERON MEDICAL LTD - ORD SHS in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of SYNERON MEDICAL LTD - ORD SHS (ELOS) as of Q1 2017

As of 31 Mar 2017, SYNERON MEDICAL LTD - ORD SHS (ELOS) was held by 88 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 24,324,137 shares. The largest 10 holders included BRANDES INVESTMENT PARTNERS, LP, NORTH TIDE CAPITAL, LLC, Camber Capital Management LLC, Senvest Management, LLC, DALTON GREINER HARTMAN MAHER & CO, Discovery Group I, LLC, ACADIAN ASSET MANAGEMENT LLC, RENAISSANCE TECHNOLOGIES LLC, Migdal Insurance & Financial Holdings Ltd., and MILLENNIUM MANAGEMENT LLC. This page lists 88 institutional shareholders reporting positions in this security for the Q1 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.